BREAKING: Coronavirus Vaccine Will Be Introduced for Clinical Trials on Monday
According to the Associated Press, the vaccine for COVID-19, or the novel coronavirus, will be available for clinical trials for the first time on Monday.
BREAKING: Government official: First dose to be delivered Monday in clinical trial for potential COVID-19 vaccine. Follow AP coverage of the virus outbreak: https://t.co/nrwRgvP6bo
— The Associated Press (@AP) March 15, 2020
The National Institutes of Health are funding the vaccine trial for coronavirus, and the first tests will take place at the Kaiser Permanente Washington Health Research Institute in Seattle. There has been no official announcement, but an insider has produced the information to the press under the condition of anonymity.
Although the clinical trials will begin tomorrow, it is expected to take between a year to 18 months before the vaccines can be approved and distributed for mass consumption. The vaccines will not likely be introduced to remedy the current outbreak.
Before the current outbreak occurred, the Gates Foundation funded a simulation for a coronavirus outbreak in which tens of millions of people died from a global pandemic. They wargamed for this scenario in 2019, just months before the novel coronavirus swept the globe.
Big League Politics has reported on the suspicious situation:
Event 201, which was hosted by the Johns Hopkins Center for Health Security, took place in October 2019 and featured a simulation in which a novel zoonotic coronavirus spread throughout the world and caused 65 million deaths worldwide. In the preparedness scenario, the coronavirus started in Brazil rather than China.
“Once you’re in the midst of a severe pandemic, your options are very limited,” said Eric Toner, a senior scholar at the Center for Health Security at Johns Hopkins University. “The greatest good can happen with pre-planning.”
The event was hosted in New York City and attended by some of the most influential business leaders, government officials, and health officials. Attendees claimed that it really helped them rethink how they would handle disaster preparedness if such a situation were to arise.
“It really does shake up assumptions and change thinking about how we can prepare for a global pandemic,” says Tom Inglesby, director of the Center for Health Security…
The Bill & Melinda Gates Foundation and globalist World Economic Forum helped to put on the event. The coronavirus was described in the training as being similar to SARS “but slightly more transmissible, like the flu, and slightly more lethal.”
“We don’t have a vaccine for SARS, or MERS, or various avian flu viruses that have come up in the past decade,” Toner said, noting how the situation described in Event 201 could easily take place. “That’s because vaccine development is slow and difficult if there isn’t an immediate market for it.”
In perhaps an even more bizarre piece of news, a vaccine-production institute also funded by Gates has obtained a patent for coronavirus:
The Pirbright Institute, which has been funded by globalist oligarch and vaccine pusher Bill Gates, has a patent on the books for coronavirus.
“The present invention provides a live, attenuated coronavirus comprising a variant replicate gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject,” the description of the patent reads.
The Bill and Melinda Gates Foundation is a known backer of the Pirbright Institute. They gave the institute $5.5 million just last year to create a Livestock Antibody Hub for disease research in humans and animals. They are deeply involved in the business of vaccine pushing.
No doubt that there will be globalists who become very rich as a result of this coronavirus crisis, as the Hegelian dialectic is once again on full display.
Share: